Related Experiment Video
Updated: Feb 3, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Guidelines to Manage Community-Acquired Pneumonia
1Department of Medicine, Pulmonary and Critical Care, Northwestern University Feinberg School of Medicine, 240 East Huron Street, McGaw M-336, Chicago, IL 60611, USA.
Community-acquired pneumonia (CAP) guidelines are widely accepted but have controversies. Evidence supports combination antibiotic therapy for hospitalized patients, with future challenges including new diagnostics and viral causes.
Area of Science:
- Infectious Diseases
- Pulmonology
- Clinical Guidelines
Background:
- Community-acquired pneumonia (CAP) management guidelines are broadly accepted but face ongoing debate and emerging challenges.
- Current guidelines vary, notably regarding the combination of macrolides and beta-lactams for non-intensive care unit hospitalized patients, a strategy supported by substantial evidence.
Purpose of the Study:
- To review current controversies and emerging challenges in community-acquired pneumonia (CAP) guideline development.
- To highlight areas of divergence with international guidelines and emphasize evidence supporting specific therapeutic approaches.
Main Methods:
- Review of existing literature and comparative analysis of international CAP management guidelines.
- Synthesis of evidence regarding combination antibiotic therapy and emerging factors influencing CAP treatment.
Main Results:
- A significant body of evidence supports the use of combination therapy (macrolides with beta-lactams) for hospitalized CAP patients not in the intensive care unit.
- Key challenges for future CAP guidelines include the integration of novel antibiotic classes, recognition of viral etiologies, advanced diagnostic tools, and management of resistant pathogens.
Conclusions:
- Combination antibiotic therapy is favored for hospitalized CAP patients based on current evidence.
- Future CAP guidelines must address evolving challenges such as viral infections, new diagnostics, antimicrobial resistance, and advanced treatments like immunomodulatory therapy for severe cases.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
What are Populations and Communities?
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...

